Communications Biology (Jul 2023)

Mendelian randomization uncovers a protective effect of interleukin-1 receptor antagonist on kidney function

  • Jeong Min Cho,
  • Jung Hun Koh,
  • Seong Geun Kim,
  • Soojin Lee,
  • Yaerim Kim,
  • Semin Cho,
  • Kwangsoo Kim,
  • Yong Chul Kim,
  • Seung Seok Han,
  • Hajeong Lee,
  • Jung Pyo Lee,
  • Kwon Wook Joo,
  • Chun Soo Lim,
  • Yon Su Kim,
  • Dong Ki Kim,
  • Sehoon Park

DOI
https://doi.org/10.1038/s42003-023-05091-8
Journal volume & issue
Vol. 6, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Interleukins (ILs), key cytokine family of inflammatory response, are closely associated with kidney function. However, the causal effect of various ILs on kidney function needs further investigation. Here we show two-sample summary-level Mendelian randomization (MR) analysis that examined the causality between serum IL levels and kidney function. Genetic variants with strong association with serum IL levels were obtained from a previous genome-wide association study meta-analysis. Summary-level data for estimated glomerular filtration rate (eGFR) were obtained from CKDGen database. As a main MR analysis, multiplicative random-effects inverse-variance weighted method was performed. Pleiotropy-robust MR analysis, including MR-Egger with bootstrapped error and weighted median methods, were also implemented. We tested the causal estimates from nine ILs on eGFR traits. Among the results, higher genetically predicted serum IL-1 receptor antagonist level was significantly associated with higher eGFR values in the meta-analysis of CKDGen and the UK Biobank data. In addition, the result was consistent towards eGFR decline phenotype of the outcome database. Otherwise, nonsignificant association was identified between other genetically predicted ILs and eGFR outcome. These findings support the clinical importance of IL-1 receptor antagonist-associated pathway in relation to kidney function in the general individuals, particularly highlighting the importance of IL-1 receptor antagonist.